医学
内科学
耐火材料(行星科学)
贝伐单抗
结直肠癌
肿瘤科
化疗
癌症
生物
天体生物学
作者
Gerald W. Prager,Julien Taı̈eb,Marwan Fakih,Fortunato Ciardiello,Eric Van Cutsem,Elena Élez,Felipe Melo Cruz,Lucjan Wyrwicz,Daniil Stroyakovskiy,Zsuzsanna Pápai,Pierre-Guillaume Poureau,Gábor Liposits,Chiara Cremolini,Igor Bondarenko,Dominik Paul Modest,Karim A. Benhadji,Nadia Amellal,Catherine Leger,Loïck Vidot,Josep Tabernero
标识
DOI:10.1056/nejmoa2214963
摘要
Among patients with refractory metastatic colorectal cancer, treatment with FTD-TPI plus bevacizumab resulted in longer overall survival than FTD-TPI alone. (Funded by Servier and Taiho Oncology; SUNLIGHT ClinicalTrials.gov number, NCT04737187; EudraCT number, 2020-001976-14.).
科研通智能强力驱动
Strongly Powered by AbleSci AI